medigraphic.com
ISSN 1817-5996 (Electronic)

2020, Number S1

<< Back Next >>

Rev Cub de Reu 2020; 22 (S1)

Advances in hyaluronic acid-based therapy for patients with osteoarthritis

Taipe RCE, Guano SCE, Quisilema PCA, Vallejo PML

Language: Spanish
References: 38
Page:
PDF size: 520.79 Kb.


ABSTRACT

Osteoarthritis is considered one of the main causes of functional disability. Osteoarthritis conceptualized as a chronic and degenerative disease that presents a peak incidence in people older than 60 years. To show advances in hyaluronic acid-based therapy for patients with osteoarthritis. Hyaluronic acid has functions in the joint that include lubrication, which serves as a filling of space to allow the joint to remain open and the regulation of cellular activities such as protein binding. Hyaluronic acid is a potential drug to help reduce the side effects of osteoarthritis.


REFERENCES

  1. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) Osteoarthr Cartil. 2013;21(1):16-21. Doi: https://doi.org/10.1016/j.joca.2012.11.012

  2. Quintero M. Osteoartrosis: biología, fisiopatología, clínica y tratamiento. Buenos Aires: Editorial Médica Panamericana; 2010.

  3. Solis U, Hernández IM, Prada DM, de Armas A, Ulloa A. Calidad de vida relacionada con la salud en pacientes con osteoartritis. Rev Cubana Reumatol. 2013 [Acceso 25/01/2020];15(3):153-9. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/280

  4. Zhang W. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137-62.

  5. Brosseau L. The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part one: introduction, and mind-body exercise programs. Clin Rehabil. 2017;31(5):582-95.

  6. Brosseau L. The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part three: aerobic exercise programs. Clin Rehabil. 2017;31(5):612-24. Doi: https://doi.org/10.1177/0269215517691085

  7. Brien S, Prescott P, Lewith G. Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methyl sulfonyl methane in the treatment of osteoarthritis of the knee. Evid Based Complement Alternat Med. 2011:528403. Doi: https://doi.org/10.1093/ecam/nep045

  8. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351-61.

  9. González S, Soto M. Eficacia del ácido hialurónico en el tratamiento de las enfermedades articulares. Rev Cubana de Reumatol. 2018 [Acceso 25/01/2020];20(3):e34. Diponible en http://scielo.sld.cu/scielo.php?script=sci_serial&pid=1817-5996&lng=es&nrm=iso

  10. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818-39.

  11. Oe M. Oral hyaluronan relieves knee pain: a review. Nutr J. 2016;15:11. Doi: https://doi.org/10.1186/s12937-016-0128-2

  12. Asari A, Kanemitsu T, Kurihara H. Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J Biol Chem. 2010;285(32):24751-8.

  13. Tashiro T. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo controlled study over a 12-month period. Sci World J. 2012:167928.

  14. Bellamy N. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;19(2):Cd005321.

  15. Bannuru RR. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis -meta-analysis. Osteoarthritis Cartilage. 2011;19(6):611-19.

  16. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: metaanalyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-79.

  17. Cooper C, Rannou F, Richette P, Bruyere O, Al-Daghri N, Altman RD, et al. Use of intraarticular hyaluronic acid in the Management of Knee Osteoarthritis in clinical practice. Arthritis Care Res (Hoboken). 2017;69(9):1287-96.

  18. Maheu E, Rannou F, Reginster JY. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S28-33.

  19. Alonso G, Villanueva P. Aplicaciones clínicas y efectos terapéuticos de la viscosuplementación en la artrosis de rodilla. Rev Ortop Traumatol. 2002;5:458-64.

  20. Fernández A, Couceiro JM, Cotón F. Estudio multicéntrico de la eficacia del tratamiento intraarticular con ácido hialurónico (Adant(r)) en artrosis de rodilla. Rev Esp Reumatol. 2003;30(2):57-65.

  21. Castellano JA, Pérez A. Evidencia de la eficacia del ácido hialurónico intraarticular en el tratamiento de la artrosis de rodilla. Rev Soc Val Reuma. 2007;2(2):61-2.

  22. Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. Product differences in intraarticular hyaluronic acids for osteoarthritis of the knee. Am J Sports Med. 2016 Aug;44(8):2158-65. Doi: https://doi.org/10.1177/0363546515609599

  23. Julin J, Jamsen E, Puolakka T, Konttinen YT, Moilanen T. Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis. A follow-up study of 32,019 total knee replacements in the Finnish arthroplasty register. Acta Orthop. 2010;81(4):413-9.

  24. Hermans J, Koopmanschap MA, Bierma-Zeinstra SM, van Linge JH, Verhaar JA, Reijman M, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res (Hoboken). 2012;64(6):853-61.

  25. Panuccio E, Memeo A, Richetta S. Evaluation of the combined treatment of oral viscosupplementation with hyaluronic acid intra-articular injection on symptomatic knee osteoarthritis. Clin Ter. 2015;166(5):e321-e6. Doi: https://doi.org/10.7417/T.2015.1886

  26. Baier Leach J. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng. 2003;82(5):578-89.

  27. Xu X. Hyaluronic acid-based hydrogels: from a Natural Polysaccharide to Complex Networks. Soft Matter. 2012;8(12):3280-94.

  28. Fakhari A. Biomedical application of hyaluronic acid nanoparticles. (PhD thesis(. Kansas: Faculty of the University of Kansas. Jan 19, 2012. [Acceso 25/01/2020]. Disponible en: https://kuscholarworks.ku.edu/bitstream/handle/1808/9825/Fakhari_ku_0099D_11965_DATA_1.pdf;sequence=1

  29. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011;23(12):H41-H56.

  30. Sun SF. Comparison of single intra-articular injection of novel hyaluronan (HYA-JOINT Plus) with synvisc-one for knee osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety. J Bone Joint Surg Am. 2017;99(6):462-71.

  31. Hangody L. Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (cingal) to provide symptomatic relief of osteoarthritis of the knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial. Cartilage. 2018 Jul;9(3):276-83. Doi: https://doi.org/10.1177/1947603517703732

  32. Tamura T. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models. Arthritis Res Ther. 2016;18:79.

  33. Ishikawa M. Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis. Osteoarthr Cartil. 2014;22(11):1902-9.

  34. Zille H. Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees. Biomed Mater Eng. 2010;20(3):235-42.

  35. Morgen M. Nanoparticles for improved local retention after intra-articular injection into the knee joint. Pharm Res. 2013;30(1):257-68.

  36. McAlindon TE. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-88.

  37. Hochberg MC. American College of Rheumatology 2012 recommendations for the use of non-pharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-74.

  38. Gigis I. Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia. 2016 [Acceso 25/01/2020];20(1):26-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27895439/




2020     |     www.medigraphic.com